Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pseudohyphal differentiation, a filamentous growth form of the budding yeast Saccharomyces cerevisiae, is induced by nitrogen starvation. The mechanisms by which nitrogen limitation regulates this process are currently unknown. We have found that
GPA2
, one of the two heterotrimeric G protein alpha subunit homologs in yeast, regulates pseudohyphal differentiation. Deltagpa2/Deltagpa2 mutant strains have a defect in pseudohyphal growth. In contrast, a constitutively active allele of
GPA2
stimulates filamentation, even on nitrogen-rich media. Moreover, a dominant negative
GPA2
allele inhibits filamentation of wild-type strains. Several findings, including epistasis analysis and reporter gene studies, indicate that
GPA2
does not regulate the MAP kinase cascade known to regulate filamentous growth. Previous studies have implicated
GPA2
in the control of intracellular cAMP levels; we find that expression of the dominant RAS2(Gly19Val) mutant or exogenous cAMP suppresses the Deltagpa2 pseudohyphal defect. cAMP also stimulates filamentation in strains lacking the cAMP
phosphodiesterase
PDE2, even in the absence of nitrogen starvation. Our findings suggest that
GPA2
is an element of the nitrogen sensing machinery that regulates pseudohyphal differentiation by modulating cAMP levels.
...
PMID:Yeast pseudohyphal growth is regulated by GPA2, a G protein alpha homolog. 938 80